Scinai Immunotherapeutics (SCNI) Accumulated Depreciation & Amortization (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $5.9 million as the latest value for Q4 2025.

• Quarterly Accumulated Depreciation & Amortization rose 31.87% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2025, up 31.87% year-over-year, with the annual reading at $5.9 million for FY2025, 31.87% up from the prior year.
• Accumulated Depreciation & Amortization hit $5.9 million in Q4 2025 for Scinai Immunotherapeutics, up from $4.5 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.9 million in Q4 2025 to a low of $4.5 million in Q4 2024.

Peer Comparison